House lawmakers on Tuesday (March 28) launched a bipartisan caucus to promote legislation that incentivizes domestic production of essential medicines to stave off future drug shortages, reduce the government’s reliance on international drug manufacturing, and ensure a steady supply of critical drugs during public health crises and natural disasters. The launch of the Domestic Pharmaceutical Manufacturing Caucus aligns with increasing congressional interest in preventing shortages of critical medications, and comes just after the Biden administration announced a plan to produce...